The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics

Mahalatchimy, Aurelie and Faulkner, Alex (2017) The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics. Regenerative Medicine, 12 (6). pp. 611-622. ISSN 1746-0751

[img] PDF - Accepted Version
Restricted to SRO admin only until 3 October 2018.

Download (581kB)

Abstract

Aims
This paper aims to map the trends and analyse key institutional dynamics that are constituting the policies for reimbursement of Regenerative Medicine (RM), especially in the UK.

Materials & Methods
Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi- structured interviews.

Results
Reimbursement has been a growing topic of publications specific to RM and independent from orphan drugs. Risk- sharing schemes receive attention amongst others for dealing with RM reimbursement. Trade organisations have been especially involved on RM reimbursement issues and have proposed solutions.

Conclusion
The policy and institutional landscape of reimbursement studies in RM is a highly variegated and conflictual one and in its infancy.

Item Type: Article
Schools and Departments: School of Global Studies > International Relations
Depositing User: Sharon Krummel
Date Deposited: 25 Oct 2017 13:12
Last Modified: 25 Oct 2017 13:12
URI: http://sro.sussex.ac.uk/id/eprint/70651

View download statistics for this item

📧 Request an update